Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy | Synapse

February 17, 2021Open Access

Ver artículo completo

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Once-daily relugolix combination therapy resulted in a significant reduction in menstrual bleeding, as compared with placebo, and preserved bone mineral density in women with uterine fibroids. (Funded by Myovant Sciences; LIBERTY 1 L1 and LIBERTY 2 L2 ClinicalTrials.gov numbers, NCT03049735 and NCT03103087, respectively.).

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Al‐Hendy et al. (Wed,) studied this question.

synapsesocial.com/papers/69d924fe9402b8412aa3c57e https://doi.org/https://doi.org/10.1056/nejmoa2008283

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo